Related Experiment Video
Updated: Apr 16, 2026

12:09
Protocol for Human Blastoids Modeling Blastocyst Development and Implantation
Published on: August 10, 2022
7.7K
Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst
Panagiotis Xenopoulos1, Minjung Kang2, Alberto Puliafito3
1Developmental Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
Cell Reports
|March 11, 2015
Summary
Early embryo development shows irreversible cell fate choices. Rapid cell proliferation and apoptosis accompany lineage commitment, suggesting developmental timing prevents fluctuating cell fates in vivo.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Genomics
Background:
- The inner cell mass (ICM) of the blastocyst gives rise to epiblast (EPI) and primitive endoderm (PrE) progenitors.
- Pluripotency-associated factors mark the EPI lineage, with dynamic expression observed in vitro.
- In vivo dynamics of these factors during ICM fate choice remain unclear.
Purpose of the Study:
- To investigate in vivo cell fate decisions within the ICM.
- To determine if pluripotency factor fluctuations in vivo correlate with lineage commitment.
- To characterize the temporal dynamics of EPI and PrE lineage specification.
Main Methods:
- Single-cell resolution quantitative imaging of a Nanog transcriptional reporter in vivo.
- Analysis of cell apoptosis and proliferation rates during ICM development.
- Observation of lineage transitions between EPI and PrE progenitors.
Main Results:
- Identified irreversible commitment to EPI/PrE lineages in vivo.
- Observed apoptosis coinciding with ICM cell fate choice, followed by EPI proliferation.
- Documented occasional PrE-to-EPI transitions, but not vice versa, suggesting regulated fate decisions.
Conclusions:
- Early mammalian embryonic development involves rapid, irreversible cell fate choices.
- Developmental timing and regulated transitions, rather than stochastic fluctuations, likely govern ICM lineage specification.
- The rapid pace of early development may preclude fluctuating cell fates in vivo.
Related Concept Videos
Somatic to iPS Cell Reprogramming
2.9K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.9K
Maintenance of the ES Cell State
2.8K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
2.8K

